Nephroblastoma, also known as Wilms tumor, is the most common kidney cancer in children, affecting mostly those under 5 years old. While this diagnosis can feel overwhelming, the good news is that with today’s treatment approaches—combining surgery, chemotherapy, and sometimes radiation therapy—most children can be cured and go on to live full, healthy lives. Treatment choices depend on the size of the tumor, whether it has spread to other parts of the body, and the specific characteristics of the cancer cells under the microscope.

How Treatment Decisions Are Made

When a child is diagnosed with nephroblastoma, the medical team develops a treatment plan based on several important factors. The stage of the disease plays a crucial role—this describes whether the cancer is confined to one kidney, has spread to nearby tissues, or has traveled to distant organs like the lungs or liver. The type of cells seen under the microscope, called histology, also matters greatly. Some tumor cells look more abnormal than others, and this affects how aggressive the treatment needs to be.^[1][4]

Doctors also consider the child’s age, overall health, and whether the tumor affects one kidney or both. In rare cases, tumors appear in both kidneys at the same time, which requires special treatment strategies to preserve kidney function while still eliminating the cancer. The goal is always to cure the disease while minimizing long-term side effects, because many of these children will live for decades after treatment.^[2][11]

Treatment for nephroblastoma has evolved significantly over the years. Medical societies and cooperative study groups in different parts of the world have developed guidelines based on decades of research and clinical trials. These guidelines help doctors choose the most effective combination of therapies while avoiding unnecessary treatments that could cause harm. The approach used in North America may differ slightly from protocols in Europe, but both have achieved excellent survival rates.^[4][11]

Surgery: The Foundation of Treatment

Surgery is the cornerstone of nephroblastoma treatment. In most cases, the first step is removing the affected kidney along with the tumor, a procedure called a nephrectomy. The surgeon carefully removes not just the kidney but also surrounding fatty tissue and nearby lymph nodes to check if cancer has spread beyond the kidney itself. This operation provides critical information about the stage of the disease and helps guide further treatment decisions.^[7][9]

The timing of surgery can vary depending on the treatment approach. In North America, doctors typically perform surgery first, then give chemotherapy based on what they find during the operation. In Europe, the standard approach often involves giving chemotherapy before surgery to shrink the tumor, making it easier and safer to remove. Both strategies have proven successful, and the choice often depends on the specific characteristics of the tumor and the medical center’s experience.^[4][10]

Sometimes the tumor is so large that it becomes difficult to remove safely without damaging nearby organs or blood vessels. In these situations, doctors may use chemotherapy first to reduce the tumor’s size. This approach, called neoadjuvant chemotherapy, can make the surgery less complicated and reduce the risk of the tumor rupturing during removal. If cancer cells spill into the abdomen during surgery, it can change the stage of the disease and require more intensive treatment afterward.^[9][10]

When tumors affect both kidneys, surgery becomes more challenging because doctors must try to preserve enough kidney tissue for the child to maintain adequate kidney function. This may involve removing only the tumor and a small margin of healthy tissue rather than the entire kidney. These children often need chemotherapy before surgery to shrink the tumors as much as possible, giving surgeons the best chance of saving healthy kidney tissue on both sides.^[11][4]

Chemotherapy: Attacking Cancer with Medications

Chemotherapy uses powerful medications to kill cancer cells throughout the body. Nearly all children with nephroblastoma receive some form of chemotherapy, either before surgery, after surgery, or both. The specific drugs used, how long treatment lasts, and how intensively they are given all depend on the stage and characteristics of the tumor.^[4][10]

The most commonly used chemotherapy drugs for nephroblastoma include actinomycin D (also called dactinomycin), vincristine, and doxorubicin. These medications work in different ways to stop cancer cells from growing and dividing. Actinomycin D interferes with the cancer cell’s ability to copy its genetic material. Vincristine prevents cancer cells from dividing by disrupting structures they need to split into two cells. Doxorubicin damages the DNA inside cancer cells, preventing them from multiplying.^[10][11]

The duration of chemotherapy varies widely. Children with very early-stage disease and favorable tumor characteristics might receive treatment for only a few months. Those with more advanced disease or unfavorable cell types may need chemotherapy for six months to a year or even longer. The medications are typically given through an intravenous line in cycles, with breaks in between to allow the child’s body to recover from side effects.^[4][11]

Some children develop low blood cell counts during chemotherapy, which can make them more susceptible to infections, bleeding, or fatigue. Regular blood tests monitor these levels, and doctors may adjust medication doses or delay treatment if counts become too low. In some cases, medications that stimulate blood cell production may be given to help the bone marrow recover more quickly between chemotherapy cycles.^[11]

For children with tumors that have unfavorable characteristics under the microscope—cells that look very abnormal, called anaplastic histology—more intensive chemotherapy regimens are needed. These may include additional drugs like cyclophosphamide and etoposide, which work through different mechanisms to attack cancer cells. While these regimens are more aggressive and may cause more side effects, they significantly improve outcomes for children whose tumors would otherwise be more difficult to cure.^[10][11]

Radiation Therapy: Targeting Remaining Cancer Cells

Radiation therapy uses high-energy beams to kill cancer cells in specific areas of the body. Not all children with nephroblastoma need radiation therapy—its use depends on the stage of the disease and whether cancer has spread beyond the kidney. Children with very early-stage disease typically do not require radiation, while those with more advanced tumors often benefit from this additional treatment.^[4][10]

When radiation is needed, it is usually directed at the area where the tumor was located in the abdomen. This helps eliminate any microscopic cancer cells that may have been left behind after surgery. Children whose cancer has spread to the lungs typically receive radiation to the chest as well. The radiation oncologist carefully calculates the dose and precisely targets the treatment area to maximize effectiveness while minimizing exposure to healthy tissues.^[10][11]

Radiation therapy is typically given five days a week for several weeks. Each treatment session lasts only a few minutes, though preparation and positioning take additional time. The actual radiation exposure is painless, but young children may need sedation to help them stay completely still during treatment, as even small movements can affect the accuracy of the radiation beam.^[11]

Side effects of radiation therapy depend on the area being treated and the dose given. Abdominal radiation can cause nausea, diarrhea, and temporary skin irritation in the treated area. Chest radiation may cause lung inflammation or difficulty swallowing. Long-term effects are possible, particularly in growing children, and may include slower growth of muscles and bones in the treated area, and in rare cases, an increased risk of developing a second cancer many years later. Modern radiation techniques have become much more precise, significantly reducing these risks compared to treatments used decades ago.^[11]

Innovative Approaches Being Studied in Clinical Trials

While standard treatments cure most children with nephroblastoma, researchers continue to explore new therapies that might improve outcomes for those with high-risk disease or cancer that has returned after treatment. Clinical trials test these new approaches in carefully controlled studies to determine if they are safe and more effective than existing treatments.^[4][11]

One area of active investigation involves targeted therapies that focus on specific molecules involved in cancer cell growth. Unlike traditional chemotherapy, which affects all rapidly dividing cells, targeted therapies are designed to interfere with particular pathways that cancer cells use to survive and multiply. Researchers are studying drugs that block signals telling cancer cells to grow, or that prevent tumors from developing new blood vessels they need to thrive.^[11]

Scientists have identified several genetic changes that occur in nephroblastoma cells. Alterations in genes called WT1, CTNNB1, and WTX are found in about one-third of these tumors. Understanding these genetic changes helps researchers develop new drugs that specifically target the abnormal proteins produced by these altered genes. Some studies are exploring whether matching treatment to a tumor’s specific genetic profile can improve outcomes while reducing side effects.^[2][11]

Immunotherapy, which harnesses the body’s own immune system to fight cancer, represents another promising area of research. These treatments help immune cells recognize and attack cancer cells more effectively. While immunotherapy has shown dramatic success in some adult cancers, its role in treating nephroblastoma is still being evaluated in early-phase clinical trials. Researchers are particularly interested in whether immunotherapy might help children whose disease has come back after standard treatment.^[11]

For children whose cancer returns or doesn’t respond to standard therapy, clinical trials may offer access to newer drugs or treatment combinations not yet widely available. These trials carefully monitor patients to assess both the effectiveness of the new treatment and any side effects that occur. Participation in clinical trials has contributed to the dramatic improvement in survival rates seen over the past several decades, as successful new approaches eventually become part of standard care.^[4][11]

Some trials are investigating whether certain children might safely receive less intensive treatment. For those with very favorable tumors that are caught early, studies are exploring whether reducing chemotherapy doses or avoiding radiation therapy can maintain cure rates while decreasing long-term side effects. This approach, called risk-adapted therapy, tailors treatment intensity to each child’s individual risk, avoiding overtreatment when possible.^[11]

Clinical trials for nephroblastoma are conducted at specialized children’s cancer centers throughout North America, Europe, and other regions. Families interested in clinical trials can discuss options with their child’s oncology team. Not every child is eligible for every trial, as studies have specific requirements regarding disease stage, previous treatments, and other factors. However, children treated on clinical trials receive the same level of care as those receiving standard treatment, often with even more intensive monitoring.^[4][11]

Most common treatment methods

• Surgery (Nephrectomy)
  • Removal of the affected kidney along with the tumor and surrounding tissue
  • May be partial nephrectomy when both kidneys are affected to preserve kidney function
  • Timing may be before or after chemotherapy depending on tumor size and treatment protocol
  • Removal of nearby lymph nodes to check for cancer spread
• Chemotherapy
  • Actinomycin D (dactinomycin) to interfere with cancer cell DNA copying
  • Vincristine to prevent cancer cells from dividing
  • Doxorubicin to damage DNA inside cancer cells
  • Cyclophosphamide and etoposide for unfavorable histology tumors
  • Duration ranges from a few months to a year depending on disease stage
  • Given through intravenous line in cycles with recovery breaks
• Radiation Therapy
  • High-energy beams targeted at tumor site in abdomen
  • Chest radiation when cancer has spread to lungs
  • Used for more advanced stages or unfavorable tumor characteristics
  • Typically given five days per week for several weeks
  • Modern techniques provide precise targeting to minimize damage to healthy tissue
• Targeted Therapy (in clinical trials)
  • Drugs targeting specific molecules involved in cancer cell growth
  • Treatments based on genetic changes found in tumor cells
  • Focus on alterations in WT1, CTNNB1, and WTX genes
  • Designed to block signals that tell cancer cells to grow
• Immunotherapy (in clinical trials)
  • Treatments that help the immune system recognize and attack cancer cells
  • Being evaluated for children with recurrent disease
  • Early-phase studies exploring effectiveness in nephroblastoma

Managing Side Effects During Treatment

Treatment for nephroblastoma can cause various side effects that affect children differently. The medical team works closely with families to manage these effects and keep children as comfortable as possible throughout their treatment journey. Understanding what to expect and how to respond can help families feel more prepared and confident.^[11]

Nausea and vomiting are common during chemotherapy, but modern anti-nausea medications have become very effective at preventing and controlling these symptoms. Doctors prescribe these medications before chemotherapy begins and continue them for several days after each treatment. Simple strategies like eating small, frequent meals and avoiding strong odors can also help children feel better. Maintaining adequate nutrition is important, though many children experience decreased appetite during treatment.^[11]

Hair loss occurs with many of the chemotherapy drugs used for nephroblastoma. While emotionally difficult for many children and families, this side effect is temporary, and hair regrows once treatment is completed. Some families find it helpful to prepare by cutting hair short before it falls out or selecting wigs or head coverings in advance. Child life specialists and support groups can provide valuable guidance on helping children cope with visible changes.^[11]

Increased infection risk is one of the most serious potential side effects of chemotherapy. When white blood cell counts drop, children become more vulnerable to infections that their bodies would normally fight off easily. Families learn to take precautions like frequent handwashing, avoiding crowds during periods of low blood counts, and watching for signs of infection such as fever. Any fever during chemotherapy requires immediate medical attention, as infections can become serious quickly in children with low white blood cell counts.^[11]

Life After Treatment

Most children with nephroblastoma are cured and go on to live normal, healthy lives. However, life after cancer treatment involves ongoing follow-up care to monitor for any late effects of therapy and to watch for the rare possibility of cancer returning. The intensity and duration of follow-up care depend on the stage of disease at diagnosis and the treatments received.^[11]

Children who had a kidney removed can live completely normal lives with their remaining kidney. A single healthy kidney can perform all necessary functions, and most children experience no limitations in physical activity or lifestyle. However, protecting the remaining kidney becomes important, which means avoiding activities with high risk of abdominal injury and promptly treating any urinary tract infections.^[11]

Some treatments, particularly certain chemotherapy drugs, can affect heart function over time. Children who received doxorubicin need regular heart monitoring, even years after treatment ends. Similarly, radiation therapy can affect the growth and development of tissues in the treated area. Children who received abdominal radiation may experience slower growth or changes in the function of organs in the radiation field. Regular follow-up allows doctors to identify and manage these issues early.^[11]

Survivors of childhood cancer, including nephroblastoma, need ongoing health monitoring throughout their lives. They should maintain regular contact with healthcare providers who understand the late effects of cancer treatment. Many cancer centers have survivorship clinics specifically designed to provide long-term follow-up care for childhood cancer survivors, helping them maintain the best possible health as they grow into adulthood.^[11]